PMC:3359311 / 1081-1393 JSONTXT

{"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T371","span":{"begin":100,"end":105},"obj":"P01584"},{"id":"T372","span":{"begin":168,"end":173},"obj":"P01584"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":"imulation. PBMCs from CF patients and controls displayed similar levels of caspase-1 activation and IL-1β production when stimulated with inflammasome activators. This IL-1β production was dependent on NF-κB activity and could be enhanced by priming with LPS. Finally, chemical inhibition of CFTR activity in con"}

{"project":"bionlp-st-ge-2016-reference","denotations":[{"id":"T55","span":{"begin":100,"end":105},"obj":"Protein"},{"id":"T56","span":{"begin":106,"end":116},"obj":"Gene_expression"},{"id":"T57","span":{"begin":122,"end":132},"obj":"Positive_regulation"},{"id":"T58","span":{"begin":168,"end":173},"obj":"Protein"}],"relations":[{"id":"R34","pred":"themeOf","subj":"T55","obj":"T56"},{"id":"R35","pred":"themeOf","subj":"T56","obj":"T57"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"imulation. PBMCs from CF patients and controls displayed similar levels of caspase-1 activation and IL-1β production when stimulated with inflammasome activators. This IL-1β production was dependent on NF-κB activity and could be enhanced by priming with LPS. Finally, chemical inhibition of CFTR activity in con"}

{"project":"bionlp-st-ge-2016-reference-tees","denotations":[{"id":"T818","span":{"begin":75,"end":84},"obj":"Protein"},{"id":"T819","span":{"begin":100,"end":105},"obj":"Protein"},{"id":"T820","span":{"begin":85,"end":95},"obj":"Positive_regulation"},{"id":"T821","span":{"begin":106,"end":116},"obj":"Gene_expression"},{"id":"T822","span":{"begin":85,"end":95},"obj":"Positive_regulation"},{"id":"T823","span":{"begin":168,"end":173},"obj":"Protein"},{"id":"T824","span":{"begin":202,"end":207},"obj":"Protein"},{"id":"T825","span":{"begin":174,"end":184},"obj":"Gene_expression"},{"id":"T826","span":{"begin":189,"end":198},"obj":"Positive_regulation"},{"id":"T827","span":{"begin":230,"end":238},"obj":"Positive_regulation"},{"id":"T828","span":{"begin":292,"end":296},"obj":"Protein"},{"id":"T831","span":{"begin":278,"end":288},"obj":"Negative_regulation"}],"relations":[{"id":"R675","pred":"themeOf","subj":"T818","obj":"T820"},{"id":"R676","pred":"themeOf","subj":"T819","obj":"T821"},{"id":"R677","pred":"themeOf","subj":"T821","obj":"T822"},{"id":"R678","pred":"themeOf","subj":"T823","obj":"T825"},{"id":"R679","pred":"themeOf","subj":"T825","obj":"T826"},{"id":"R680","pred":"themeOf","subj":"T825","obj":"T827"},{"id":"R681","pred":"themeOf","subj":"T828","obj":"T831"}],"text":"imulation. PBMCs from CF patients and controls displayed similar levels of caspase-1 activation and IL-1β production when stimulated with inflammasome activators. This IL-1β production was dependent on NF-κB activity and could be enhanced by priming with LPS. Finally, chemical inhibition of CFTR activity in con"}

{"project":"events-check-again","denotations":[{"id":"T785","span":{"begin":100,"end":105},"obj":"Protein"},{"id":"T786","span":{"begin":106,"end":116},"obj":"Gene_expression"},{"id":"T787","span":{"begin":122,"end":132},"obj":"Positive_regulation"},{"id":"T788","span":{"begin":168,"end":173},"obj":"Protein"}],"relations":[{"id":"R656","pred":"themeOf","subj":"T785","obj":"T786"},{"id":"R657","pred":"themeOf","subj":"T786","obj":"T787"}],"text":"imulation. PBMCs from CF patients and controls displayed similar levels of caspase-1 activation and IL-1β production when stimulated with inflammasome activators. This IL-1β production was dependent on NF-κB activity and could be enhanced by priming with LPS. Finally, chemical inhibition of CFTR activity in con"}

{"project":"bionlp-st-ge-2016-spacy-parsed","denotations":[{"id":"T529","span":{"begin":9,"end":10},"obj":"."},{"id":"T530","span":{"begin":11,"end":16},"obj":"NNS"},{"id":"T531","span":{"begin":17,"end":21},"obj":"IN"},{"id":"T532","span":{"begin":22,"end":24},"obj":"NNP"},{"id":"T533","span":{"begin":25,"end":33},"obj":"NNS"},{"id":"T534","span":{"begin":34,"end":37},"obj":"CC"},{"id":"T535","span":{"begin":38,"end":46},"obj":"NNS"},{"id":"T536","span":{"begin":47,"end":56},"obj":"VBD"},{"id":"T537","span":{"begin":57,"end":64},"obj":"JJ"},{"id":"T538","span":{"begin":65,"end":71},"obj":"NNS"},{"id":"T539","span":{"begin":72,"end":74},"obj":"IN"},{"id":"T540","span":{"begin":75,"end":84},"obj":"JJ"},{"id":"T541","span":{"begin":85,"end":95},"obj":"NN"},{"id":"T542","span":{"begin":96,"end":99},"obj":"CC"},{"id":"T543","span":{"begin":100,"end":105},"obj":"JJ"},{"id":"T544","span":{"begin":106,"end":116},"obj":"NN"},{"id":"T545","span":{"begin":117,"end":121},"obj":"WRB"},{"id":"T546","span":{"begin":122,"end":132},"obj":"VBN"},{"id":"T547","span":{"begin":133,"end":137},"obj":"IN"},{"id":"T548","span":{"begin":138,"end":150},"obj":"JJ"},{"id":"T549","span":{"begin":151,"end":161},"obj":"NNS"},{"id":"T550","span":{"begin":161,"end":162},"obj":"."},{"id":"T551","span":{"begin":163,"end":167},"obj":"DT"},{"id":"T552","span":{"begin":168,"end":173},"obj":"JJ"},{"id":"T553","span":{"begin":174,"end":184},"obj":"NN"},{"id":"T554","span":{"begin":185,"end":188},"obj":"VBD"},{"id":"T555","span":{"begin":189,"end":198},"obj":"JJ"},{"id":"T556","span":{"begin":199,"end":201},"obj":"IN"},{"id":"T557","span":{"begin":202,"end":207},"obj":"JJ"},{"id":"T558","span":{"begin":208,"end":216},"obj":"NN"},{"id":"T559","span":{"begin":217,"end":220},"obj":"CC"},{"id":"T560","span":{"begin":221,"end":226},"obj":"MD"},{"id":"T561","span":{"begin":227,"end":229},"obj":"VB"},{"id":"T562","span":{"begin":230,"end":238},"obj":"VBN"},{"id":"T563","span":{"begin":239,"end":241},"obj":"IN"},{"id":"T564","span":{"begin":242,"end":249},"obj":"VBG"},{"id":"T565","span":{"begin":250,"end":254},"obj":"IN"},{"id":"T566","span":{"begin":255,"end":258},"obj":"NNP"},{"id":"T567","span":{"begin":258,"end":259},"obj":"."},{"id":"T568","span":{"begin":260,"end":267},"obj":"RB"},{"id":"T569","span":{"begin":267,"end":268},"obj":","},{"id":"T570","span":{"begin":269,"end":277},"obj":"NN"},{"id":"T571","span":{"begin":278,"end":288},"obj":"NN"},{"id":"T572","span":{"begin":289,"end":291},"obj":"IN"},{"id":"T573","span":{"begin":292,"end":296},"obj":"NNP"},{"id":"T574","span":{"begin":297,"end":305},"obj":"NN"},{"id":"T575","span":{"begin":306,"end":308},"obj":"IN"}],"relations":[{"id":"R468","pred":"nsubj","subj":"T530","obj":"T536"},{"id":"R469","pred":"prep","subj":"T531","obj":"T530"},{"id":"R470","pred":"compound","subj":"T532","obj":"T533"},{"id":"R471","pred":"pobj","subj":"T533","obj":"T531"},{"id":"R472","pred":"cc","subj":"T534","obj":"T533"},{"id":"R473","pred":"conj","subj":"T535","obj":"T533"},{"id":"R474","pred":"ROOT","subj":"T536","obj":"T536"},{"id":"R475","pred":"amod","subj":"T537","obj":"T538"},{"id":"R476","pred":"dobj","subj":"T538","obj":"T536"},{"id":"R477","pred":"prep","subj":"T539","obj":"T538"},{"id":"R478","pred":"amod","subj":"T540","obj":"T541"},{"id":"R479","pred":"pobj","subj":"T541","obj":"T539"},{"id":"R480","pred":"cc","subj":"T542","obj":"T541"},{"id":"R481","pred":"amod","subj":"T543","obj":"T544"},{"id":"R482","pred":"conj","subj":"T544","obj":"T541"},{"id":"R483","pred":"advmod","subj":"T545","obj":"T546"},{"id":"R484","pred":"advcl","subj":"T546","obj":"T536"},{"id":"R485","pred":"prep","subj":"T547","obj":"T546"},{"id":"R486","pred":"amod","subj":"T548","obj":"T549"},{"id":"R487","pred":"pobj","subj":"T549","obj":"T547"},{"id":"R488","pred":"punct","subj":"T550","obj":"T536"},{"id":"R489","pred":"det","subj":"T551","obj":"T553"},{"id":"R490","pred":"compound","subj":"T552","obj":"T553"},{"id":"R491","pred":"nsubj","subj":"T553","obj":"T554"},{"id":"R492","pred":"ROOT","subj":"T554","obj":"T554"},{"id":"R493","pred":"acomp","subj":"T555","obj":"T554"},{"id":"R494","pred":"prep","subj":"T556","obj":"T555"},{"id":"R495","pred":"amod","subj":"T557","obj":"T558"},{"id":"R496","pred":"pobj","subj":"T558","obj":"T556"},{"id":"R497","pred":"cc","subj":"T559","obj":"T554"},{"id":"R498","pred":"aux","subj":"T560","obj":"T562"},{"id":"R499","pred":"auxpass","subj":"T561","obj":"T562"},{"id":"R500","pred":"conj","subj":"T562","obj":"T554"},{"id":"R501","pred":"prep","subj":"T563","obj":"T562"},{"id":"R502","pred":"pcomp","subj":"T564","obj":"T563"},{"id":"R503","pred":"prep","subj":"T565","obj":"T564"},{"id":"R504","pred":"pobj","subj":"T566","obj":"T565"},{"id":"R505","pred":"punct","subj":"T567","obj":"T554"},{"id":"R508","pred":"compound","subj":"T570","obj":"T571"},{"id":"R510","pred":"prep","subj":"T572","obj":"T571"},{"id":"R511","pred":"amod","subj":"T573","obj":"T574"},{"id":"R512","pred":"pobj","subj":"T574","obj":"T572"},{"id":"R513","pred":"prep","subj":"T575","obj":"T574"}],"text":"imulation. PBMCs from CF patients and controls displayed similar levels of caspase-1 activation and IL-1β production when stimulated with inflammasome activators. This IL-1β production was dependent on NF-κB activity and could be enhanced by priming with LPS. Finally, chemical inhibition of CFTR activity in con"}

{"project":"pmc-enju-pas","denotations":[{"id":"T235","span":{"begin":11,"end":16},"obj":"NN"},{"id":"T236","span":{"begin":17,"end":21},"obj":"IN"},{"id":"T237","span":{"begin":22,"end":24},"obj":"NN"},{"id":"T238","span":{"begin":25,"end":33},"obj":"NN"},{"id":"T239","span":{"begin":34,"end":37},"obj":"CC"},{"id":"T240","span":{"begin":38,"end":46},"obj":"NN"},{"id":"T241","span":{"begin":47,"end":56},"obj":"VB"},{"id":"T242","span":{"begin":57,"end":64},"obj":"JJ"},{"id":"T243","span":{"begin":65,"end":71},"obj":"NN"},{"id":"T244","span":{"begin":72,"end":74},"obj":"IN"},{"id":"T245","span":{"begin":75,"end":84},"obj":"NN"},{"id":"T246","span":{"begin":85,"end":95},"obj":"NN"},{"id":"T247","span":{"begin":96,"end":99},"obj":"CC"},{"id":"T248","span":{"begin":100,"end":105},"obj":"NN"},{"id":"T249","span":{"begin":106,"end":116},"obj":"NN"},{"id":"T250","span":{"begin":117,"end":121},"obj":"WRB"},{"id":"T251","span":{"begin":122,"end":132},"obj":"VB"},{"id":"T252","span":{"begin":133,"end":137},"obj":"IN"},{"id":"T253","span":{"begin":138,"end":150},"obj":"JJ"},{"id":"T254","span":{"begin":151,"end":161},"obj":"NN"},{"id":"T255","span":{"begin":163,"end":167},"obj":"DT"},{"id":"T256","span":{"begin":168,"end":173},"obj":"NN"},{"id":"T257","span":{"begin":174,"end":184},"obj":"NN"},{"id":"T258","span":{"begin":185,"end":188},"obj":"VB"},{"id":"T259","span":{"begin":189,"end":198},"obj":"JJ"},{"id":"T260","span":{"begin":199,"end":201},"obj":"IN"},{"id":"T261","span":{"begin":202,"end":207},"obj":"NN"},{"id":"T262","span":{"begin":208,"end":216},"obj":"NN"},{"id":"T263","span":{"begin":217,"end":220},"obj":"CC"},{"id":"T264","span":{"begin":221,"end":226},"obj":"MD"},{"id":"T265","span":{"begin":227,"end":229},"obj":"VB"},{"id":"T266","span":{"begin":230,"end":238},"obj":"VB"},{"id":"T267","span":{"begin":239,"end":241},"obj":"IN"},{"id":"T268","span":{"begin":242,"end":249},"obj":"VB"},{"id":"T269","span":{"begin":250,"end":254},"obj":"IN"},{"id":"T270","span":{"begin":255,"end":258},"obj":"NN"},{"id":"T271","span":{"begin":260,"end":267},"obj":"RB"},{"id":"T272","span":{"begin":267,"end":268},"obj":"-COMMA-"},{"id":"T273","span":{"begin":269,"end":277},"obj":"JJ"},{"id":"T274","span":{"begin":278,"end":288},"obj":"NN"},{"id":"T275","span":{"begin":289,"end":291},"obj":"IN"},{"id":"T276","span":{"begin":292,"end":296},"obj":"NN"},{"id":"T277","span":{"begin":297,"end":305},"obj":"NN"},{"id":"T278","span":{"begin":306,"end":308},"obj":"IN"}],"relations":[{"id":"R186","pred":"arg1Of","subj":"T235","obj":"T236"},{"id":"R187","pred":"arg1Of","subj":"T235","obj":"T241"},{"id":"R188","pred":"arg1Of","subj":"T238","obj":"T237"},{"id":"R189","pred":"arg1Of","subj":"T238","obj":"T239"},{"id":"R190","pred":"arg2Of","subj":"T239","obj":"T236"},{"id":"R191","pred":"arg2Of","subj":"T240","obj":"T239"},{"id":"R192","pred":"arg1Of","subj":"T241","obj":"T250"},{"id":"R193","pred":"arg2Of","subj":"T243","obj":"T241"},{"id":"R194","pred":"arg1Of","subj":"T243","obj":"T242"},{"id":"R195","pred":"arg1Of","subj":"T243","obj":"T244"},{"id":"R196","pred":"arg1Of","subj":"T246","obj":"T245"},{"id":"R197","pred":"arg1Of","subj":"T246","obj":"T247"},{"id":"R198","pred":"arg2Of","subj":"T247","obj":"T244"},{"id":"R199","pred":"arg2Of","subj":"T249","obj":"T247"},{"id":"R200","pred":"arg1Of","subj":"T249","obj":"T248"},{"id":"R201","pred":"arg2Of","subj":"T251","obj":"T250"},{"id":"R202","pred":"arg1Of","subj":"T251","obj":"T252"},{"id":"R203","pred":"arg2Of","subj":"T254","obj":"T252"},{"id":"R204","pred":"arg1Of","subj":"T254","obj":"T253"},{"id":"R205","pred":"arg1Of","subj":"T257","obj":"T255"},{"id":"R206","pred":"arg1Of","subj":"T257","obj":"T256"},{"id":"R207","pred":"arg1Of","subj":"T257","obj":"T258"},{"id":"R208","pred":"arg1Of","subj":"T257","obj":"T259"},{"id":"R209","pred":"arg1Of","subj":"T257","obj":"T264"},{"id":"R210","pred":"arg1Of","subj":"T257","obj":"T265"},{"id":"R211","pred":"arg2Of","subj":"T257","obj":"T266"},{"id":"R212","pred":"arg1Of","subj":"T258","obj":"T263"},{"id":"R213","pred":"arg2Of","subj":"T259","obj":"T258"},{"id":"R214","pred":"arg1Of","subj":"T259","obj":"T260"},{"id":"R215","pred":"arg2Of","subj":"T262","obj":"T260"},{"id":"R216","pred":"arg1Of","subj":"T262","obj":"T261"},{"id":"R217","pred":"arg2Of","subj":"T266","obj":"T263"},{"id":"R218","pred":"arg2Of","subj":"T266","obj":"T264"},{"id":"R219","pred":"arg2Of","subj":"T266","obj":"T265"},{"id":"R220","pred":"arg1Of","subj":"T266","obj":"T267"},{"id":"R221","pred":"arg2Of","subj":"T268","obj":"T267"},{"id":"R222","pred":"arg1Of","subj":"T268","obj":"T269"},{"id":"R223","pred":"arg2Of","subj":"T270","obj":"T269"},{"id":"R224","pred":"arg1Of","subj":"T274","obj":"T273"},{"id":"R225","pred":"arg1Of","subj":"T274","obj":"T275"},{"id":"R226","pred":"arg1Of","subj":"T274","obj":"T278"},{"id":"R229","pred":"arg2Of","subj":"T277","obj":"T275"},{"id":"R230","pred":"arg1Of","subj":"T277","obj":"T276"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"imulation. PBMCs from CF patients and controls displayed similar levels of caspase-1 activation and IL-1β production when stimulated with inflammasome activators. This IL-1β production was dependent on NF-κB activity and could be enhanced by priming with LPS. Finally, chemical inhibition of CFTR activity in con"}

{"project":"sentences","denotations":[{"id":"T82","span":{"begin":11,"end":162},"obj":"Sentence"},{"id":"T83","span":{"begin":163,"end":259},"obj":"Sentence"},{"id":"T12","span":{"begin":11,"end":162},"obj":"Sentence"},{"id":"T13","span":{"begin":163,"end":259},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"imulation. PBMCs from CF patients and controls displayed similar levels of caspase-1 activation and IL-1β production when stimulated with inflammasome activators. This IL-1β production was dependent on NF-κB activity and could be enhanced by priming with LPS. Finally, chemical inhibition of CFTR activity in con"}